• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期原发性结肠癌的修订管理:2例病例系列

Revised management of advanced primary colon cancer: Case series of 2 patients.

作者信息

Sugarbaker Paul H, Hassanein Mohamed T

机构信息

Center for Gastrointestinal Malignancies, Program in Peritoneal Surface Oncology, Washington Cancer Institute, Washington, DC, USA.

Department of Surgery, MedStar Washington Hospital Center, Washington, DC, USA.

出版信息

Int J Surg Case Rep. 2019;55:233-238. doi: 10.1016/j.ijscr.2019.01.046. Epub 2019 Feb 10.

DOI:10.1016/j.ijscr.2019.01.046
PMID:30776587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6378842/
Abstract

BACKGROUND

The resection of a primary colon cancer has the opportunity to cure the patient of cancer by complete clearance and absolute containment of disease. Alternatively, if the cancer resection does not provide clearance and containment it will eventuate in local recurrence and peritoneal dissemination.

METHODS

Culpability of recurrence of colorectal cancer is difficult to determine. Are the management strategies of the primary cancer evaluation and treatment at fault or is the underlying disease process is to be held responsible? The clinical and radiologic findings that could have been evaluated by a multidisciplinary team (MDT) were critically evaluated in 2 patients with right colon adenocarcinoma. Strategies to accomplish complete clearance and absolute containment of the primary malignancy as resectable for cure were suggested.

RESULTS

Clinical evaluation of these 2 patients suggested that more knowledgeable preoperative evaluation by the multidisciplinary team (MDT) should have placed them in a high risk group for local recurrence and/or peritoneal dissemination. High carcinoembryonic antigen (CEA) tumor marker and by CT a large primary cancer infiltrating adjacent structures can be used to select advanced pre- and intraoperative treatment strategies.

CONCLUSIONS

Two patients who had an approximately 50% possibility of long-term survival with optimal preoperative evaluation and expert surgical resection techniques may have been converted to a greatly reduced survival because of tumor dissemination and positive margins of resection at the time of primary cancer resection. Neither patient was evaluated by an MDT preoperatively. It is possible that these two patients entered the operating room with a contained malignancy but as result of suboptimal pre- and intraoperative management left the operating room with disseminated intraperitoneal disease.

摘要

背景

原发性结肠癌切除术有机会通过彻底清除和完全控制疾病来治愈患者。否则,如果癌症切除不能实现清除和控制,将会导致局部复发和腹膜播散。

方法

结直肠癌复发的责任难以确定。是原发性癌症评估和治疗的管理策略有误,还是潜在的疾病进程应承担责任?对2例右半结肠癌患者的临床和影像学检查结果进行了严格评估,这些结果本可由多学科团队(MDT)进行评估。提出了实现对可切除的原发性恶性肿瘤进行彻底清除和完全控制的策略,以达到治愈目的。

结果

对这2例患者的临床评估表明,多学科团队(MDT)更专业的术前评估本应将他们归为局部复发和/或腹膜播散的高风险组。高癌胚抗原(CEA)肿瘤标志物以及CT显示的侵犯相邻结构的大的原发性癌症可用于选择先进的术前和术中治疗策略。

结论

两名患者若进行最佳的术前评估和采用专业的手术切除技术,原本有大约50%的长期生存可能性,但由于原发性癌症切除时肿瘤播散和切缘阳性,其生存可能性可能已大幅降低。这两名患者术前均未接受多学科团队(MDT)的评估。有可能这两名患者进入手术室时癌症局限,但由于术前和术中管理欠佳,离开手术室时已出现腹膜内疾病播散。

相似文献

1
Revised management of advanced primary colon cancer: Case series of 2 patients.晚期原发性结肠癌的修订管理:2例病例系列
Int J Surg Case Rep. 2019;55:233-238. doi: 10.1016/j.ijscr.2019.01.046. Epub 2019 Feb 10.
2
Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.原发性结肠癌伴腹膜转移癌的治疗:同步治疗与延迟治疗的比较
Dis Colon Rectum. 2000 Oct;43(10):1341-6; discussion 1347-8. doi: 10.1007/BF02236627.
3
It Is What the Surgeon Does Not See That Kills the Patient.正是外科医生没有看到的东西害死了病人。
J Clin Med. 2024 Apr 12;13(8):2238. doi: 10.3390/jcm13082238.
4
Surgical management of recurrent colon cancer.复发性结肠癌的外科治疗
J Gastrointest Oncol. 2020 Jun;11(3):513-525. doi: 10.21037/jgo-2019-ccm-09.
5
HIPEC plus EPIC paclitaxel for maximal perioperative treatments of advanced epithelial ovarian cancer. Long-term results of a pilot study.HIPEC 联合 EPIC 紫杉醇治疗晚期上皮性卵巢癌的最大围手术期治疗。一项初步研究的长期结果。
Surg Oncol. 2020 Dec;35:441-446. doi: 10.1016/j.suronc.2020.09.019. Epub 2020 Sep 28.
6
Successful management of microscopic residual disease in large bowel cancer.大肠癌微小残留病的成功管理。
Cancer Chemother Pharmacol. 1999;43 Suppl:S15-25. doi: 10.1007/s002800051093.
7
Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.辅助性热灌注腹腔化疗(HIPEC)用于有腹膜播散高危风险的结肠癌患者;COLOPEC随机多中心试验
BMC Cancer. 2015 May 24;15:428. doi: 10.1186/s12885-015-1430-7.
8
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial.局部晚期结肠癌患者的辅助腹腔内热化疗(COLOPEC):一项多中心、开放标签、随机试验。
Lancet Gastroenterol Hepatol. 2019 Oct;4(10):761-770. doi: 10.1016/S2468-1253(19)30239-0. Epub 2019 Jul 29.
9
Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer.结直肠癌患者局部复发和腹膜转移预防的最新进展
World J Gastroenterol. 2014 Jul 28;20(28):9286-91. doi: 10.3748/wjg.v20.i28.9286.
10
Strategies to improve local control of resected pancreas adenocarcinoma.改善切除的胰腺腺癌局部控制的策略。
Surg Oncol. 2017 Mar;26(1):63-70. doi: 10.1016/j.suronc.2017.01.002. Epub 2017 Jan 18.

引用本文的文献

1
Duodenectomy with jejunal advancement and reimplantation of the ampulla of Vater for recurrent right colon cancer: A case report.十二指肠切除术联合空肠推进及Vater壶腹再植术治疗复发性右结肠癌:一例报告
Int J Surg Case Rep. 2019;62:1-4. doi: 10.1016/j.ijscr.2019.07.022. Epub 2019 Jul 19.

本文引用的文献

1
Laparoscopic conversion in colorectal cancer surgery; is there any improvement over time at a population level?腹腔镜结直肠癌手术中转:在人群水平上是否随着时间的推移而有所改善?
Surg Endosc. 2018 Jul;32(7):3234-3246. doi: 10.1007/s00464-018-6042-2. Epub 2018 Jan 17.
2
Preferred reporting of case series in surgery; the PROCESS guidelines.外科手术病例系列报告的首选方法:PROCESS 指南。
Int J Surg. 2016 Dec;36(Pt A):319-323. doi: 10.1016/j.ijsu.2016.10.025. Epub 2016 Oct 19.
3
Improving oncologic outcomes for colorectal cancer at high risk for local-regional recurrence with novel surgical techniques.
采用新型手术技术改善局部区域复发高危结直肠癌的肿瘤学结局。
Expert Rev Gastroenterol Hepatol. 2016;10(2):205-13. doi: 10.1586/17474124.2016.1110019. Epub 2015 Dec 7.
4
Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial.局部进展期可切除结肠癌术前化疗的可行性:一项随机对照试验的初步阶段。
Lancet Oncol. 2012 Nov;13(11):1152-60. doi: 10.1016/S1470-2045(12)70348-0. Epub 2012 Sep 25.
5
Accuracy of multidetector computed tomography in identifying poor prognostic factors in colonic cancer.多排螺旋 CT 对结肠癌不良预后因素的诊断准确性。
Br J Surg. 2010 Sep;97(9):1407-15. doi: 10.1002/bjs.7096.
6
Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma.广泛术中腹腔灌洗作为胃癌患者腹腔复发的标准预防策略。
Ann Surg. 2009 Aug;250(2):242-6. doi: 10.1097/SLA.0b013e3181b0c80e.
7
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.在MOSAIC试验中,奥沙利铂、氟尿嘧啶和亚叶酸作为II期或III期结肠癌辅助治疗可提高总生存率。
J Clin Oncol. 2009 Jul 1;27(19):3109-16. doi: 10.1200/JCO.2008.20.6771. Epub 2009 May 18.
8
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.卡培他滨、伊立替康和奥沙利铂序贯与联合化疗用于晚期结直肠癌(CAIRO):一项III期随机对照试验
Lancet. 2007 Jul 14;370(9582):135-142. doi: 10.1016/S0140-6736(07)61086-1.
9
Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.结直肠癌的预后因素。美国病理学家学会1999年共识声明
Arch Pathol Lab Med. 2000 Jul;124(7):979-94. doi: 10.5858/2000-124-0979-PFICC.
10
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis.腹膜癌患者诊断和分期的临床研究方法
Cancer Treat Res. 1996;82:359-74. doi: 10.1007/978-1-4613-1247-5_23.